Development and Validation of a Simulation Model–Based Clinical Decision Tool: Identifying Patients Where 21-Gene Recurrence Score Testing May Change Decisions

There is a need for industry-independent decision tools that integrate clinicopathologic features, comorbidities, and genomic information for women with node-negative, invasive, hormone receptor–positive, human epidermal growth factor receptor-2–negative (early-stage) breast cancer. METHODS: We adap...

Descripción completa

Detalles Bibliográficos
Autores principales: Jayasekera, Jinani, Sparano, Joseph A., O'Neill, Suzanne, Chandler, Young, Isaacs, Claudine, Kurian, Allison W., Kushi, Lawrence, Schechter, Clyde B., Mandelblatt, Jeanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2021
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425835/
https://www.ncbi.nlm.nih.gov/pubmed/34251881
http://dx.doi.org/10.1200/JCO.21.00651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425835/
https://www.ncbi.nlm.nih.gov/pubmed/34251881
http://dx.doi.org/10.1200/JCO.21.00651

Ejemplares similares